Senior insider sale
KESTRA MEDICAL TECHNOLOGIES, LTD. — senior position signals high conviction
$97.5K
3.33K shares
What this filing means
COHEN RAYMOND W plans to sell 3.33K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. valued at approximately $97.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/30/2026ACC: 0001964306-26-000458
Director
Since Mar 2025
3.33K
Shares to sell
$97.5K
Approx. market value
3.33K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit awards
Granted as part of issuer equity compensation plan
9/4/2026
3.33KTotal acquired3.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/4/2026 | Vesting of restricted stock unit awards Granted as part of issuer equity compensation plan | 3.33K | — |
| Total | 3.33K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.33K
Market value
$97.5K
9/30/2026
Total
Units
3.33K
Value
$97.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/30/2026 | 3.33K | $97.5K | NASDAQ | Planned |
| Total | 3.33K | $97.5K | ||